Document and Entity Information - USD ($)

12 Months Ended

Dec. 31, 2023

Feb. 28, 2024

Jun. 30, 2023

Cover [Abstract]

Document Type

10-K

Document Annual Report

true

Document Transition Report

false

Document Period End Date

Dec. 31, 2023

Entity File Number

001-39539

Entity Registrant Name

PMV PHARMACEUTICALS, INC.

Entity Incorporation, State or Country Code

DE

Entity Tax Identification Number

46-3218129

Entity Address, Address Line One

1 Research Way

Entity Address, City or Town

Princeton

Entity Address, State or Province

NJ

Entity Address, Postal Zip Code

08540

City Area Code

609

Local Phone Number

642-6670

Title of 12(b) Security

Common stock, par value $0.00001

Trading Symbol

PMVP

Security Exchange Name

NASDAQ

Entity Well-known Seasoned Issuer

No

Entity Voluntary Filers

No

Entity Current Reporting Status

Yes

Entity Interactive Data Current

Yes

Entity Filer Category

Non-accelerated Filer

Document Financial Statement Error Correction

false

Entity Small Business

true

Entity Emerging Growth Company

false

Entity Shell Company

false

Entity Common Stock, Shares Outstanding

51,443,488

Entity Public Float

$ 209,239,411

Current Fiscal Year End Date

--12-31

Document Fiscal Year Focus

2023

Document Fiscal Period Focus

FY

Entity Central Index Key

0001699382

Amendment Flag

false

ICFR Auditor Attestation Flag

false

Auditor Firm ID

42

Auditor Name

Ernst & Young LLP

Auditor Location

Philadelphia, Pennsylvania

Documents Incorporated by Reference

DOCUMENTS INCORPORATED BY REFERENCE

Portions of the Registrant’s definitive Proxy Statement relating to the 2024 Annual Meeting of Stockholders are incorporated herein by reference in Part III of this Annual Report on Form 10-K to the extent stated herein. Such proxy statement will be filed with the Securities and Exchange Commission within 120 days of the registrant’s fiscal year ended December 31, 2023.